(C) 2023 Electronic News Publishing, source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,482 JPY | +1.16% | -5.73% | -12.16% |
Apr. 17 | Japan Inc makes a renewed U.S. push as China fears mount | RE |
Apr. 15 | Middle East Tensions Blunt Asian Stock Markets Excepting China | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
1,482 JPY | +1.16% | -5.73% | 17B | ||
25.39 USD | -0.12% | -3.61% | 144B | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.16% | 17B | |
+27.97% | 676B | |
+23.58% | 554B | |
-7.02% | 349B | |
+14.85% | 318B | |
+6.25% | 291B | |
+2.96% | 210B | |
-0.41% | 204B | |
-10.02% | 194B | |
-11.81% | 144B |
- Stock Market
- Equities
- 4503 Stock
- News Astellas Pharma Inc.
- Astellas Pharma Inc. - XTANDI plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide